Concepedia

Publication | Open Access

Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes

DOIFull Paper Access

210

Citations

14

References

2010

Year

J. Michael Gaziano, Anthony H. Cincotta, Christopher M. O’Connor, Michael Ezrokhi, Dean Rutty, Zhulin Ma, Richard E. Scranton
Diabetes Care

Abstract

The frequency of SAEs was comparable between the treatment arms. Compared with patients in the placebo arm, fewer patients taking bromocriptine-QR experienced a cardiovascular end point.

References

YearCitations

Page 1